1 - 5 of 5 articles
“Science should be driving our drug policies, even if it makes us uncomfortable.”
The ripples toward deregulating buprenorphine became a tsunami last week. This time, it's aiming straight for Congress, as the Trump administration's clumsy attempt to steer it through the last days of the previous administration failed. Among the new voices added to the debate: patient advocacy...
The federal Department of Health and Human Services (HHS), which under former President Donald Trump threatened to open up patient record protections under the Health Insurance Portability and Accountability Act (HIPAA; see “In case you haven't heard,” ADAW, Jan. 11,...
Mark Weber, whom we have known for our entire career as a master public affairs official in the federal government, is now acting assistant secretary for public affairs (ASPA), the top communications job interfacing with the media and others, at the Department of Health and Human Services (HHS)....
CADCA's 31st national leadership forum, and SAMHSA's 17th prevention day, will be held virtually February1‐February 4, 2021. For more information, go to https://www.cadca.org/forum2021.
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.